Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults-Reply

Affiliations

Comment

Edward T Qian et al. JAMA. 2024.

. 2024 Feb 27;331(8):709-710.

doi: 10.1001/jama.2023.27891.

¹ Division of Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

No abstract available

Comment on

Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults.
Dequidt T, Markowicz S, Coussement J. Dequidt T, et al. JAMA. 2024 Feb 27;331(8):708. doi: 10.1001/jama.2023.27900. JAMA. 2024. PMID: 38411649 No abstract available.
Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults.
Chanderraj R, Dickson RP, Sjoding MW. Chanderraj R, et al. JAMA. 2024 Feb 27;331(8):707-708. doi: 10.1001/jama.2023.27897. JAMA. 2024. PMID: 38411650 No abstract available.
Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults.
Chen D, Ren H, Zhao Y. Chen D, et al. JAMA. 2024 Feb 27;331(8):708-709. doi: 10.1001/jama.2023.27894. JAMA. 2024. PMID: 38411651 No abstract available.